Kamis, 01 Desember 2016

AstraZeneca in broad drug deal with Bicycle worth up to $1 bln

LONDON, Dec 1 (Reuters) - AstraZeneca has signed a wide-ranging deal with private biotech firm Bicycle Therapeutics to develop a novel class of small molecule medicines for treating respiratory, cardiovascular and metabolic diseases.

from Reuters: New Issues News http://ift.tt/2gCfIyK

Tidak ada komentar:

Posting Komentar